# DESCRIPTION

## FIELD

- define fields of invention

## BACKGROUND

- introduce inflammatory diseases
- describe benefits of limited inflammation
- describe harm of unchecked inflammation
- distinguish between microbial, autoimmune, and metabolic inflammation
- describe chronic microbial inflammation
- describe Hepatitis C virus infection
- introduce Toll-like receptors
- describe intracellular signaling complexes
- introduce stress-responsive transcription factors
- describe genomic response to proinflammatory insults
- introduce nuclear factor kappa B
- describe importins and nuclear localization sequences
- introduce Sterol Response Element-Binding Proteins
- describe limitations of conventional therapeutics
- motivate need for new anti-inflammatory therapeutics

## BRIEF SUMMARY

- introduce disease treatment
- describe inflammatory diseases
- motivate nuclear transport modulation
- introduce importin alpha and beta
- describe importin beta-selective NTM
- describe importin alpha-selective NTM
- introduce cell-penetrating peptides
- introduce nucleic acids
- introduce small molecules
- describe advantages over steroidal anti-inflammatory drugs
- describe advantages over non-steroidal anti-inflammatory drugs
- define Nuclear Transport Modifiers
- define importin beta-selective NTM
- define importin alpha-selective NTM
- define nuclear import adaptor
- define cargo
- describe specific and selective cargo
- define protein and polypeptide
- define gene
- define nucleic acid
- define patient, subject, and individual
- define bind and interact with
- define labeled
- define therapeutic and therapeutic agent
- define treatment
- describe composition for treating inflammatory disease
- describe method of treating or preventing inflammation
- describe method of treating or preventing inflammation with importin alpha-selective NTM
- describe method of treating or preventing inflammation with importin alpha and beta inhibitor
- describe kit for treating or preventing inflammation
- describe method of treatment for wound healing
- describe routes of administration
- describe prior art
- conclude invention

## DETAILED DESCRIPTION

- describe compositions and methods for treating diseases mediated by inflammation
- analyze interaction of NTM hydrophilic module with endogenous human importins/karyopherins alpha
- determine mechanism of NTM modulation of importin alpha-mediated nuclear transport
- identify Imp α5 as a target for anti-inflammatory action of cell-penetrating peptides or their mimetics
- identify importins alpha-specific peptides based on autoinhibitory regions of importins alpha
- identify different intracellular lifespans of importins alpha and a method of their extension
- identify importins alpha diversity regions for their use as a platform for design of peptides and peptide mimetics
- design, synthesize and test an importin beta-selective NTM
- describe NTMs that target nuclear transport adaptors
- describe modulation of signaling to the nucleus mediated by transcription factors
- describe examples of NTMs including SN50, cSN50, and cSN50.1
- describe generation and use of SN50

### Biological and Chemical Methods

- describe methods involving conventional molecular biology techniques
- describe techniques generally known in the art
- describe compositions for treating diseases associated with inflammation
- describe pharmaceutically acceptable carrier and at least one importin beta-selective and/or at least one importin alpha-selective NTM
- describe modification of entry into the nucleus of at least one transcription factor
- describe reduction of entry of at least one SREBP into the nucleus
- describe importin beta-selective NTM that reduces nuclear translocation of SREBP1a, SREBP1c, and SREBP
- describe examples of importin beta-selective NTMs
- describe peptides designed to inhibit interaction of importin alpha with importin beta
- describe peptides designed to be specific inhibitors of importins alpha
- describe derivatives and/or analogues of sequences
- describe NTM as an inhibitor of an importin alpha 3 interaction with importin beta
- describe SI-3 sequence designed to block an interaction between importin alpha and importin beta
- describe peptides in which any of the amino acids in the SSHR are replaced
- describe importin alpha 5-selective NTM
- describe methods of treating or preventing inflammatory disorders in a mammalian subject
- describe administration of a composition including at least one importin beta-selective NTM
- describe reduction of importin alpha-mediated nuclear translocation of SRTFs
- describe reduction of importin beta-mediated nuclear translocation of transcription factors

### Kits

- describe kits for treating diseases or disorders associated with inflammation in a subject
- describe composition including a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one importin beta-selective NTM

### Administration of Pharmaceutical Compositions

- introduce pharmaceutical compositions
- describe administration means
- specify composition amounts
- describe carrier substances
- formulate for local or systemic administration
- provide dosage forms
- describe parenteral administration
- formulate for oral administration
- describe coating options
- specify excipients
- describe lubricating agents
- describe colorants and flavoring agents
- describe buffering agents
- describe enteric coating
- describe time delay materials
- describe solid tablet compositions
- describe therapeutic combinations
- describe formulations for inhalation and topical applications
- describe therapeutic methods

### Effective Doses

- describe effective amounts
- determine therapeutically effective amounts

## EXAMPLES

- provide examples

### Example 1—Targeting Nuclear Import Shuttles, Importins/Karyopherins Alpha, by a Peptide Mimicking the NF kappa B1/p50 Nuclear Localization Sequence

- introduce cell-penetrating nuclear transport modifier (NTM)
- report treatment outcome in mouse model of familial hypercholesterolemia
- describe anti-inflammatory function of NTMs
- motivate N50-containing NTMs
- define N50 motif patterned on NFκB1/p50 subunit
- explain SSHR motif from human fibroblast growth factor 4
- describe mechanism of NTM interaction with importins alpha
- introduce study of NTM module N50 with human importins alpha
- describe sequence analyses of importins/karyopherins alpha
- explain PeptideCutter software
- describe T-Coffee software
- introduce cell culture
- describe whole cell lysates preparation
- determine half-life of human importins
- describe synthesis and purification of peptides
- explain importin binding assays
- describe relative abundance of importins in human cells
- prepare plasmids, express and purify recombinant proteins
- determine binding affinity using Bio-Layer Interferometry
- generate in silico 3-dimensional docking models
- prepare ligand and receptor input files
- introduce statistical considerations
- describe experimental design
- motivate importin turnover analysis
- summarize importin turnover results
- discuss IκBα turnover control
- analyze importin alpha diversity regions
- introduce peptide design
- describe peptide binding studies
- summarize peptide binding results
- discuss importin alpha interactions
- analyze peptide binding patterns
- discuss importin alpha abundance
- motivate competition binding assay
- describe competition binding assay
- summarize competition binding results
- discuss specificity of peptide binding
- introduce binding affinity assay
- describe binding affinity assay
- summarize binding affinity results
- discuss 2:1 stoichiometry of peptide binding
- motivate auto-inhibitory region analysis
- describe auto-inhibitory region analysis
- summarize auto-inhibitory region results
- discuss importin alpha auto-inhibitory regions
- discuss implications of results
- summarize findings
- conclude
- introduce peptide docking models
- verify AutoDock Vina software accuracy
- generate 3-D coordinates of peptide chains
- model docking of N50 peptide to Imp α1 and α5
- analyze docking affinities and binding energies
- compare binding affinities of N50 and N50M sequences
- identify structural elements stabilizing interactions
- discuss molecular modeling results
- introduce importin alpha family and NLS binding pockets
- discuss N50 peptide interactions with importins alpha
- describe accelerated turnover of importins in stimulated T cells
- propose mechanism of proteasomal degradation
- discuss implications of Imp α5 turnover in stimulated cells
- propose targeting Imp α5 by N50 sequence and NTM congeners
- discuss viability and fertility of Imp α5-deficient mice
- summarize findings on NTM peptides and nuclear transport
- present Table 2: amino acid sequences of peptides used
- present Table 3: nomenclature and sequence identity of importins
- present Table 4: characteristics of N50-Imp α interactions
- conclude discussion

## OTHER EMBODIMENTS

- incorporate prior art
- define invention scope

